Who Exports Sulfamethoxazole from India — 145 Suppliers Behind a $19.8M Market
India's sulfamethoxazole export market is supplied by 145 active exporters who collectively shipped $19.8M across 877 shipments. MICRO LABS LIMITED leads with a 36.8% market share, followed by AUROBINDO PHARMA LIMITED and FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 55.9% of total export value, reflecting a moderately competitive market structure.
Top Sulfamethoxazole Exporters from India — Ranked by Export Value
MICRO LABS LIMITED is the leading sulfamethoxazole exporter from India, holding a 36.8% share of the $19.8M market across 877 shipments from 145 exporters. The top 5 suppliers — MICRO LABS LIMITED, AUROBINDO PHARMA LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, APL HEALTHCARE LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED — collectively control 55.9% of total export value, indicating a moderately concentrated market. Individual shares are: MICRO LABS LIMITED (36.8%), AUROBINDO PHARMA LIMITED (5.6%), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED (5.3%), APL HEALTHCARE LIMITED (4.5%), AMNEAL PHARMACEUTICALS PRIVATE LIMITED (3.8%).
Top Sulfamethoxazole Exporters from India
Ranked by export value · 145 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MICRO LABS LIMITED TRIMETHOPRIM AND SULFAMETHOXAZOLE TABLETTRIMETHOPRIM & SULFAMETHOXAZOLE 160/800MG KGSSULFAMETHOXAZOLE AND TRIMETHOPRIM TABLET | $7.3M | 19 | 36.8% |
| 2 | AUROBINDO PHARMA LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $1.1M | 1 | 5.6% |
| 3 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED COTRIMOXAZOLE TABLET BP 480MGCOTRIMOXAZOLE TABLET BP 480MG NOS | $1.0M | 3 | 5.3% |
| 4 | APL HEALTHCARE LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $891.1K | 1 | 4.5% |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $744.8K | 1 | 3.8% |
| 6 | MICRO LABS LTD TRIMETHOPRIM AND SULFAMETHOXAZOLE TABLETTRIMETHOPRIM & SULFAMETHOXAZOLE 160/800MG KGSSULFAMETHOXAZOLE AND TRIMETHOPRIM TABLET | $681.2K | 3 | 3.4% |
| 7 | SOMERSET THERAPEUTICS LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $616.2K | 1 | 3.1% |
| 8 | JODAS EXPOIM PRIVATE LIMITED SULFAMETHOXAZOLE + TRIMETHOPRIM CONCENTRSULFAMETHOXAZOLE+TRIMETHOPRIM CONCENTRAT | $481.8K | 1 | 2.4% |
| 9 | MEDREICH LIMITED SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETPHARTRIM SUSPENSIONSULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS 100X10S NOS | $454.4K | 1 | 2.3% |
| 10 | MEDICAMEN BIOTECH LIMITED | $442.8K | 2 | 2.2% |
| 11 | CIPLA LIMITED TRIMETHOPRIM & SULFAMETHOXAZOLE 160/800MG KGSSULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETTRIMETHOPRIM AND SULFAMETHOXAZOLE TABLET | $404.2K | 6 | 2.0% |
| 12 | SYNCOM FORMULATIONS (INDIA) LIMITED | $395.8K | 5 | 2.0% |
| 13 | CAPLIN POINT LABORATORIES LIMITED | $291.6K | 5 | 1.5% |
| 14 | EUGIA PHARMA SPECIALITIES LIMITED | $277.4K | 1 | 1.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Sulfamethoxazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Micro Labs Limited | Warning Letter, January 2 | Unknown | Unknown | Not verified | Received FDA warning letter in January 2015 for data integrity issues. |
| Aurobindo Pharma Limited | Approved | Unknown | Unknown | Multiple | Received FDA warning letter in June 2019; has multiple FDA approvals. |
| Eugia Pharma Specialities Limited | Approved | Unknown | Unknown | Multiple | Wholly owned subsidiary of Aurobindo Pharma; received FDA approval for Vancomyci |
TransData Nexus reviewed the regulatory standing of 3 leading Sulfamethoxazole exporters from India. 2 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Sulfamethoxazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. This robust infrastructure positions Hyderabad as a pivotal player in the supply chain of antibiotics like Sulfamethoxazole.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Vadodara, in particular, is a major hub for pharmaceutical industries, housing numerous companies involved in the manufacturing of formulations. This specialization in formulations complements the bulk drug production capabilities of other regions, ensuring a seamless supply chain for finished pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for India's pharmaceutical products. Mumbai's strategic location and well-established port facilities facilitate the efficient export of pharmaceuticals to global markets. This region's infrastructure supports the distribution of drugs like Sulfamethoxazole to international destinations, including Zimbabwe and the United States, which are among the top importers.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. These incentives have attracted numerous pharmaceutical companies, contributing to the region's growth as a manufacturing hub. While not directly linked to Sulfamethoxazole production, the region's overall pharmaceutical output supports the industry's supply chain.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Leverage Export Infrastructure: Utilize the export capabilities of the Mumbai-Thane-Raigad region to ensure timely delivery to international markets.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements to maintain product integrity.
- Assess Cost-Benefit of Tax Incentives: Evaluate the financial advantages of sourcing from tax incentive zones like Baddi-Nalagarh to optimize procurement costs.
By strategically sourcing from these specialized clusters, TransData Nexus can enhance the efficiency and reliability of its Sulfamethoxazole supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Sulfamethoxazole exporters from India
Aurobindo Pharma Limited — Aurobindo acquires 51% stake in GLS Pharma Limited
In August 2022, Aurobindo Pharma Limited acquired a 51% stake in GLS Pharma Limited, enhancing its oncology product portfolio. - IMPACT: This acquisition is expected to strengthen Aurobindo's position in the oncology segment, potentially influencing its Sulfamethoxazole export capabilities.
Impact: This acquisition is expected to strengthen Aurobindo's position in the oncology segment, potentially influencing its Sulfamethoxazole export capabilities.
Aurobindo Pharma Limited — Aurobindo's subsidiary Theranym Biologics incorporated
In September 2022, Theranym Biologics Private Limited was incorporated as a wholly owned subsidiary of Curateq Biologics Private Limited, a part of Aurobindo Pharma. - IMPACT: The establishment of Theranym Biologics may lead to diversification in Aurobindo's product offerings, with potential indirect effects on Sulfamethoxazole exports.
Impact: The establishment of Theranym Biologics may lead to diversification in Aurobindo's product offerings, with potential indirect effects on Sulfamethoxazole exports.
Micro Labs Limited — Income Tax Department raids Micro Labs
In July 2022, the Indian Income Tax Department conducted raids on multiple premises of Micro Labs Limited, uncovering alleged tax evasion and unaccounted distribution of freebies to medical professionals. - IMPACT: These regulatory challenges could impact Micro Labs' financial stability and, consequently, its Sulfamethoxazole export activities.
Impact: These regulatory challenges could impact Micro Labs' financial stability and, consequently, its Sulfamethoxazole export activities.
Common Questions — Sulfamethoxazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which sulfamethoxazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MICRO LABS LIMITED leads with 111 recorded shipments worth $7.3M. AUROBINDO PHARMA LIMITED (19 shipments) and FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED (20 shipments) are also established high-volume exporters.
Q How many sulfamethoxazole manufacturers are there in India?
India has 145 active sulfamethoxazole exporters with a combined export market of $19.8M across 877 shipments to 92 countries. The top 5 suppliers hold 55.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for sulfamethoxazole from India?
Average FOB unit price: $12.23 per unit, ranging from $0.01 to $332.36. Average shipment value: $22.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 145 verified Indian exporters of Sulfamethoxazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 877 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 92 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
877 Verified Shipments
145 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists